1. Background
2. Objectives
3. Methods
3.1. Participants
3.2. Procedures
3.3. Intervention
3.4. Statistical Analysis
4. Results
| CONb (N = 15) | NONc (N = 13) | |||
|---|---|---|---|---|
| Pre-Test | Post-Test | Pre-Test | Post-Test | |
| Body mass, kg | 67.67 ± 12.64 | 67.50 ± 11.98 | 65.87 ± 21.98 | 65.75 ± 21.39 |
| BMI, kg.m-2 | 23.05 ± 3.34 | 23.00 ± 3.11 | 22.09 ± 5.22 | 22.06 ± 5.08 |
| WC, cm | 76.79 ± 7.32 | 76.36 ± 7.45 | 73.92 ± 12.71 | 74.25 ± 13.16 |
| HC, cm | 82.01 ± 7.94 | 83.55 ± 8.05 | 79.85 ± 13.20 | 80.12 ± 11.81 |
| WHR | 0.94 ± 0.04 | 0.92 ± 0.05d | 0.93 ± 0.04 | 0.92 ± 0.06 |
| WSR | 0.45 ± 0.03 | 0.45 ± 0.03 | 0.43 ± 0.06 | 0.43 ± 0.06 |
| FFM, kg | 57.46 ± 9.16 | 58.21 ± 8.65d | 56.36 ± 8.92 | 56.76 ± 9.28 |
| %BF, % | 14.56 ± 5.96 | 13.24 ± 5.77d | 11.41 ± 10.21 | 10.85 ± 9.71 |
| FM, kg | 10.22 ± 5.31 | 9.29 ± 5.17d | 9.50 ± 13.79 | 8.98 ± 13.24 |
| ƩSKF, mm | 96.22 ± 35.64 | 87.67 ± 32.15d | 87.46 ± 83.69 | 84.62 ± 81.89 |
| CI | 43.57 ± 7.74 | 43.27 ± 7.62 | 41.78 ± 15.20 | 41.92 ± 15.3 |
| FVC, L(btps) | 3.79 ± 0.89 | 3.95 ± 0.89 | 3.95 ± 0.55 | 3.69 ± 0.55d |
| FEV1, L(btps) | 3.47 ± 0.80 | 4.70 ± 2.04 | 3.65 ± 0.45 | 3.53 ± 0.53 |
| PEF, L.sec-1 | 5.06 ± 2.04 | 6.57 ± 2.51d | 6.54 ± 2.00 | 7.53 ± 2.36 |
| FEV1/FVC, % | 87.94 ± 14.90 | 91.06 ± 6.42 | 92.57 ± 8.70 | 93.84 ± 7.47 |
| MEF75%, L.sec-1 | 4.78 ± 2.01 | 6.24 ± 1.99d | 6.18 ± 1.92 | 7.08 ± 2.54 |
| MEF50%, L.sec-1 | 4.08 ± 1.20 | 5.24 ± 1.44d | 5.19 ± 0.96 | 5.12 ± 1.33 |
| MEF25%, L.sec-1 | 2.66 ± 0.63 | 3.31 ± 1.87d | 3.10 ± 0.65 | 3.22 ± 0.53 |
Abbreviations: MEF75%, maximal expiratory flow at 75%; MEF50%, maximal expiratory flow at 50%; MEF25%, maximal expiratory flow at 25%; ƩSKF, sum of skinfolds.
aValues are presented as means ± SD.
bCON, Calisthenic concurrent aerobic and resistance training group.
cNON, Non-exercising control group.
dP ≤ 0.05 compared to pre-test.